Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Equity Ratio (2020 - 2025)

Biofrontera (BFRI) has 6 years of Equity Ratio data on record, last reported at 0.17 in Q3 2025.

  • For Q3 2025, Equity Ratio fell 156.06% year-over-year to 0.17; the TTM value through Sep 2025 reached 0.17, down 156.06%, while the annual FY2024 figure was 0.2, 16.89% up from the prior year.
  • Equity Ratio reached 0.17 in Q3 2025 per BFRI's latest filing, up from 0.23 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.51 in Q2 2024 and bottomed at 1.13 in Q3 2021.
  • Average Equity Ratio over 5 years is 0.1, with a median of 0.21 recorded in 2021.
  • Peak YoY movement for Equity Ratio: soared 881.26% in 2024, then tumbled 156.06% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.21 in 2021, then soared by 120.27% to 0.47 in 2022, then plummeted by 63.43% to 0.17 in 2023, then rose by 16.89% to 0.2 in 2024, then crashed by 183.48% to 0.17 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.17 in Q3 2025, 0.23 in Q2 2025, and 0.03 in Q1 2025.